Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial...
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
About this item
Full title
Author / Creator
for the Eastern Cooperative Oncology Group , Eastern Cooperative Oncology Group , Rajkumar, S Vincent, Prof , Jacobus, Susanna, MS , Callander, Natalie S, MD , Fonseca, Rafael, Prof , Vesole, David H, Prof , Williams, Michael E, Prof , Abonour, Rafat, MD , Siegel, David S, Prof , Katz, Michael, BS and Greipp, Philip R, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background High-dose dexamethasone is a mainstay of therapy for multiple myeloma. We studied whether low-dose dexamethasone in combination with lenalidomide is non-inferior to and has lower toxicity than high-dose dexamethasone plus lenalidomide. Methods Patients with untreated symptomatic myeloma were randomly assigned in this open-label n...
Alternative Titles
Full title
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
Authors, Artists and Contributors
Author / Creator
Eastern Cooperative Oncology Group
Rajkumar, S Vincent, Prof
Jacobus, Susanna, MS
Callander, Natalie S, MD
Fonseca, Rafael, Prof
Vesole, David H, Prof
Williams, Michael E, Prof
Abonour, Rafat, MD
Siegel, David S, Prof
Katz, Michael, BS
Greipp, Philip R, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3042271
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3042271
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(09)70284-0
